2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1,2-benzoxazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1H-indol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-[1,2]oxazolo[5,4-b]pyridin-6-yl)methyl]acetamide

C150H153N33O12 — CID 159346565

IUPAC2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1,2-benzoxazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1H-indol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-[1,2]oxazolo[5,4-b]pyridin-6-yl)methyl]acetamide
SMILESCc1[nH]nc2cc(CNC(=O)Cn3c(C)cnc(NN(Cc4ccccc4)Cc4ccccc4)c3=O)ccc12.Cc1[nH]nc2ccc(CNC(=O)Cn3c(C)cnc(NN(Cc4ccccc4)Cc4ccccc4)c3=O)cc12.Cc1c[nH]c2ccc(CNC(=O)Cn3c(C)cnc(NN(Cc4ccccc4)Cc4ccccc4)c3=O)cc12.Cc1noc2cc(CNC(=O)Cn3c(C)cnc(NN(Cc4ccccc4)Cc4ccccc4)c3=O)ccc12.Cc1noc2nc(CNC(=O)Cn3c(C)cnc(NN(Cc4ccccc4)Cc4ccccc4)c3=O)ccc12
InChIInChI=1S/C31H32N6O2.2C30H31N7O2.C30H30N6O3.C29H29N7O3/c1-22-16-32-28-14-13-26(15-27(22)28)18-33-29(38)21-37-23(2)17-34-30(31(37)39)35-36(19-24-9-5-3-6-10-24)20-25-11-7-4-8-12-25;1-21-16-32-29(35-36(18-23-9-5-3-6-10-23)19-24-11-7-4-8-12-24)30(39)37(21)20-28(38)31-17-25-13-14-27-26(15-25)22(2)33-34-27;1-21-16-32-29(35-36(18-23-9-5-3-6-10-23)19-24-11-7-4-8-12-24)30(39)37(21)20-28(38)31-17-25-13-14-26-22(2)33-34-27(26)15-25;1-21-16-32-29(33-35(18-23-9-5-3-6-10-23)19-24-11-7-4-8-12-24)30(38)36(21)20-28(37)31-17-25-13-14-26-22(2)34-39-27(26)15-25;1-20-15-31-27(33-35(17-22-9-5-3-6-10-22)18-23-11-7-4-8-12-23)29(38)36(20)19-26(37)30-16-24-13-14-25-21(2)34-39-28(25)32-24/h3-17,32H,18-21H2,1-2H3,(H,33,38)(H,34,35);2*3-16H,17-20H2,1-2H3,(H,31,38)(H,32,35)(H,33,34);3-16H,17-20H2,1-2H3,(H,31,37)(H,32,33);3-15H,16-19H2,1-2H3,(H,30,37)(H,31,33)
InChIKeyLGUKWFUSDCFKOV-UHFFFAOYSA-N
MW2610.09 g/mol
LogP20.94
Rot. Bonds50

About 2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1,2-benzoxazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1H-indol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-[1,2]oxazolo[5,4-b]pyridin-6-yl)methyl]acetamide

2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1,2-benzoxazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1H-indol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-[1,2]oxazolo[5,4-b]pyridin-6-yl)methyl]acetamide (PubChem CID 159346565) has the molecular formula C150H153N33O12 and a molecular weight of 2610.09 g/mol. Its IUPAC name is 2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1,2-benzoxazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1H-indol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-[1,2]oxazolo[5,4-b]pyridin-6-yl)methyl]acetamide.

Molecular Properties

Compound Name2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1,2-benzoxazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1H-indol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-[1,2]oxazolo[5,4-b]pyridin-6-yl)methyl]acetamide
PubChem CID159346565
Molecular FormulaC150H153N33O12
Molecular Weight2610.09 g/mol
Exact Mass2608.24
IUPAC Name2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1,2-benzoxazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1H-indol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-[1,2]oxazolo[5,4-b]pyridin-6-yl)methyl]acetamide
SMILESCc1[nH]nc2cc(CNC(=O)Cn3c(C)cnc(NN(Cc4ccccc4)Cc4ccccc4)c3=O)ccc12.Cc1[nH]nc2ccc(CNC(=O)Cn3c(C)cnc(NN(Cc4ccccc4)Cc4ccccc4)c3=O)cc12.Cc1c[nH]c2ccc(CNC(=O)Cn3c(C)cnc(NN(Cc4ccccc4)Cc4ccccc4)c3=O)cc12.Cc1noc2cc(CNC(=O)Cn3c(C)cnc(NN(Cc4ccccc4)Cc4ccccc4)c3=O)ccc12.Cc1noc2nc(CNC(=O)Cn3c(C)cnc(NN(Cc4ccccc4)Cc4ccccc4)c3=O)ccc12
InChIInChI=1S/C31H32N6O2.2C30H31N7O2.C30H30N6O3.C29H29N7O3/c1-22-16-32-28-14-13-26(15-27(22)28)18-33-29(38)21-37-23(2)17-34-30(31(37)39)35-36(19-24-9-5-3-6-10-24)20-25-11-7-4-8-12-25;1-21-16-32-29(35-36(18-23-9-5-3-6-10-23)19-24-11-7-4-8-12-24)30(39)37(21)20-28(38)31-17-25-13-14-27-26(15-25)22(2)33-34-27;1-21-16-32-29(35-36(18-23-9-5-3-6-10-23)19-24-11-7-4-8-12-24)30(39)37(21)20-28(38)31-17-25-13-14-26-22(2)33-34-27(26)15-25;1-21-16-32-29(33-35(18-23-9-5-3-6-10-23)19-24-11-7-4-8-12-24)30(38)36(21)20-28(37)31-17-25-13-14-26-22(2)34-39-27(26)15-25;1-20-15-31-27(33-35(17-22-9-5-3-6-10-22)18-23-11-7-4-8-12-23)29(38)36(20)19-26(37)30-16-24-13-14-25-21(2)34-39-28(25)32-24/h3-17,32H,18-21H2,1-2H3,(H,33,38)(H,34,35);2*3-16H,17-20H2,1-2H3,(H,31,38)(H,32,35)(H,33,34);3-16H,17-20H2,1-2H3,(H,31,37)(H,32,33);3-15H,16-19H2,1-2H3,(H,30,37)(H,31,33)
InChIKeyLGUKWFUSDCFKOV-UHFFFAOYSA-N
XLogP20.94
TPSA534.40 Ų
H-Bond Donors13
H-Bond Acceptors37
Rotatable Bonds50
Heavy Atoms195
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002610.09
LogP ≤ 520.94
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1037

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1,2-benzoxazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1H-indol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-[1,2]oxazolo[5,4-b]pyridin-6-yl)methyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1,2-benzoxazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1H-indol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-[1,2]oxazolo[5,4-b]pyridin-6-yl)methyl]acetamide?
The IUPAC name of 2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1,2-benzoxazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1H-indol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-[1,2]oxazolo[5,4-b]pyridin-6-yl)methyl]acetamide (CID 159346565) is 2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1,2-benzoxazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1H-indol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-[1,2]oxazolo[5,4-b]pyridin-6-yl)methyl]acetamide.
What is the SMILES notation for 2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1,2-benzoxazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1H-indol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-[1,2]oxazolo[5,4-b]pyridin-6-yl)methyl]acetamide?
The canonical SMILES for 2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1,2-benzoxazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1H-indol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-[1,2]oxazolo[5,4-b]pyridin-6-yl)methyl]acetamide is Cc1[nH]nc2cc(CNC(=O)Cn3c(C)cnc(NN(Cc4ccccc4)Cc4ccccc4)c3=O)ccc12.Cc1[nH]nc2ccc(CNC(=O)Cn3c(C)cnc(NN(Cc4ccccc4)Cc4ccccc4)c3=O)cc12.Cc1c[nH]c2ccc(CNC(=O)Cn3c(C)cnc(NN(Cc4ccccc4)Cc4ccccc4)c3=O)cc12.Cc1noc2cc(CNC(=O)Cn3c(C)cnc(NN(Cc4ccccc4)Cc4ccccc4)c3=O)ccc12.Cc1noc2nc(CNC(=O)Cn3c(C)cnc(NN(Cc4ccccc4)Cc4ccccc4)c3=O)ccc12.
What is the InChIKey of 2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1,2-benzoxazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1H-indol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-[1,2]oxazolo[5,4-b]pyridin-6-yl)methyl]acetamide?
The InChIKey is LGUKWFUSDCFKOV-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H32N6O2.2C30H31N7O2.C30H30N6O3.C29H29N7O3/c1-22-16-32-28-14-13-26(15-27(22)28)18-33-29(38)21-37-23(2)17-34-30(31(37)39)35-36(19-24-9-5-3-6-10-24)20-25-11-7-4-8-12-25;1-21-16-32-29(35-36(18-23-9-5-3-6-10-23)19-24-11-7-4-8-12-24)30(39)37(21)20-28(38)31-17-25-13-14-27-26(15-25)22(2)33-34-27;1-21-16-32-29(35-36(18-23-9-5-3-6-10-23)19-24-11-7-4-8-12-24)30(39)37(21)20-28(38)31-17-25-13-14-26-22(2)33-34-27(26)15-25;1-21-16-32-29(33-35(18-23-9-5-3-6-10-23)19-24-11-7-4-8-12-24)30(38)36(21)20-28(37)31-17-25-13-14-26-22(2)34-39-27(26)15-25;1-20-15-31-27(33-35(17-22-9-5-3-6-10-22)18-23-11-7-4-8-12-23)29(38)36(20)19-26(37)30-16-24-13-14-25-21(2)34-39-28(25)32-24/h3-17,32H,18-21H2,1-2H3,(H,33,38)(H,34,35);2*3-16H,17-20H2,1-2H3,(H,31,38)(H,32,35)(H,33,34);3-16H,17-20H2,1-2H3,(H,31,37)(H,32,33);3-15H,16-19H2,1-2H3,(H,30,37)(H,31,33).
What are the key properties of 2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1,2-benzoxazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1H-indol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-[1,2]oxazolo[5,4-b]pyridin-6-yl)methyl]acetamide?
2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1,2-benzoxazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1H-indol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-[1,2]oxazolo[5,4-b]pyridin-6-yl)methyl]acetamide has a molecular weight of 2610.09 g/mol, XLogP of 20.94, 50 rotatable bonds, 13 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1,2-benzoxazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-2H-indazol-6-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-1H-indol-5-yl)methyl]acetamide;2-[3-(2,2-dibenzylhydrazinyl)-6-methyl-2-oxopyrazin-1-yl]-N-[(3-methyl-[1,2]oxazolo[5,4-b]pyridin-6-yl)methyl]acetamide is sourced from PubChem (CID 159346565), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).